News from valeritas, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 08, 2015, 07:15 ET

Real-World Study Data Demonstrating That Valeritas' V-Go Consistently Reduces A1C Levels and Decreases Insulin Requirements for Patients With Diabetes Regardless of Baseline A1C Presented at ADA 2015

Valeritas Inc. announced today additional real-world study data and retrospective analyses reported by Diabetes America on Valeritas' lead...

May 18, 2015, 07:15 ET

Study Shows That Valeritas' V-Go® Improves Blood Glucose Control and Reduces Insulin Requirements in Residents of Long Term Care Facilities

Valeritas Inc. announced today that the real- world data and retrospective analyses from an ongoing study at the Meadows Nursing & Rehab...

May 15, 2015, 11:15 ET

Real-World Data from Three Separate Studies Demonstrate that Valeritas' V-Go® Significantly Reduces A1c and Lowers Total Daily Insulin Dose for Patients with Diabetes

Valeritas Inc. announced today the real-world study data and retrospective analyses reported by Diabetes America on Valeritas' lead product, V-Go....

Apr 09, 2015, 15:00 ET

Study Analysis Shows Valeritas' V-Go® Device Helps Reduce Diabetes Management Cost for Type 2 Diabetes Patients by Improving Glycemic Control and Reducing Insulin Doses

Valeritas Inc., disclosed today the results of a retrospective study analysis of the health and economic benefits of the company's lead product,...

Oct 20, 2014, 08:00 ET

Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award

Valeritas, Inc., a leader in simple, disposable basal-bolus insulin delivery technology designed for patients with Type 2 diabetes, announced today...

May 15, 2014, 15:00 ET

Interim Analysis Suggests that Delivery of Insulin via Valeritas' V-Go® Shows Promise in Improving Glycemic Control for Patients with Type 2 Diabetes Previously Taking Long-Acting Insulin

Valeritas, makers of the V-Go® Disposable Insulin Delivery Device, announced interim analysis data from SIMPLE, a prospective observational...

Jun 22, 2013, 11:13 ET

Valeritas Announces New Findings From Observational Study Suggesting That Delivery Of Insulin Via V-Go® May Improve Glycemic Control And Reduce Total Daily Insulin Dose For Patients With Type 2 Diabetes

Valeritas, makers of the V-Go® insulin delivery device, today announced new findings from a planned interim analysis of data from the SIMPLE...

Jun 04, 2013, 11:22 ET

Valeritas Closes $100 Million Financing

 Valeritas, makers of the V-Go® insulin delivery device, today announced that they have closed a structured debt financing with Capital...

May 22, 2013, 09:43 ET

Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance

Hemoglobin A1C levels increased over a four-year period for commercially-insured patients with Type 2 diabetes, while modest improvements in A1C...

May 02, 2013, 15:00 ET

New Interim Analysis From Observational Study Suggests That Delivery Of Insulin Via Valeritas' V-Go Shows Promise In Improving Glycemic Control For Patients With Type 2 Diabetes

 Valeritas, makers of the V-Go® insulin delivery device, announced new interim analysis from an observational study today that suggest...

Nov 12, 2012, 08:15 ET

Valeritas Announces The Publication Of A Retrospective Analysis Of Patient-Reported Data On The V-Go In The Current Issue Of Endocrine Practice

 Valeritas announced today the results from a recent retrospective analysis that looked at data relating to the clinical experience and...

Sep 12, 2011, 14:34 ET

Valeritas gibt Finanzierungsrunde von 150 Mio. Dollar bekannt

-- Welsh, Carson, Anderson & Stowe führten die Finanzierungsrunde und haben eine Kontrollbeteiligung an Valeritas -- Finanzierungsrunde...

Sep 12, 2011, 14:30 ET

Valeritas annonce un financement d'une valeur de 150 M $

-- Welsh, Carson, Anderson & Stowe a dirigé le financement et acquiert une participation majoritaire dans Valeritas -- Ce financement va...

Sep 12, 2011, 07:30 ET

Valeritas Announces $150 Million Financing

Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced...

Sep 12, 2011, 07:30 ET

Valeritas anuncia una financiación de 150 millones de dólares

  -- Welsh, Carson, Anderson & Stowe han liderado la financiación, y asumen los intereses de control de Valeritas -- La...

Jul 28, 2011, 08:48 ET

Valeritas reçoit l'autorisation européenne du marquage CE pour l'appareil de délivrance d'insuline jetable V-Go™

Valeritas, Inc., une société de technologie médicale se focalisant sur le développement et la commercialisation de solutions...

Jul 26, 2011, 12:04 ET

Valeritas erhält europäische CE-Zulassung für Einwegvorrichtung V-Go™ zur Insulinverabreichung

Valeritas, Inc., ein Medizintechnikunternehmen, das sich der Entwicklung und Vermarktung innovativer Lösungen für die...

Jul 25, 2011, 13:27 ET

Valeritas recibe la aprobación de Marca CE europea para el dispositivo desechable de administración de insulina V-Go™

Valeritas, Inc., una compañía de tecnología médica centrada en el desarrollo y comercialización de soluciones innovadoras...

Jul 25, 2011, 07:30 ET

Valeritas Receives European CE Mark Approval for the V-Go™ Disposable Insulin Delivery Device

Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced...

Mar 01, 2011, 07:30 ET

Valeritas Receives FDA 510(k) Clearance for the V-Go™ Disposable Insulin Delivery Device for Use with NovoLog®

Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced...